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ABSTRACT 
In the present study, two low generation triazine-based dendrimers, G1.0(Cl)4 
dendrimer and G1.5(OH)8 dendrimer, were synthesized and their cytotoxicity were 
tested by using the NIH 3T3 and the A2780 cell lines. In the synthesis process of the 
G1.0(Cl)4 dendrimer, cyanuric chloride (CAC) which has high reactivity chlorine atom 
was connected to the terminal of triethylene glycol (TEG) via nucleophilic substitution 
by controlling temperature. The prepared G1.0(Cl)4 dendrimer was purified by silica 
gel column chromatography. Then the four chlorine atoms in the G1.0(Cl)4 dendrimer 
were substituted by diethanolamine (DEA) to give dendrimer with the hydroxyl 
terminal group G1.5(OH)8. 
The starting materials, CAC, G1.0(Cl)4 dendrimer and G1.5(OH)8 dendrimer 
were analyzed by one-dimensional NMR, FTIR and MS techniques. The two 
dendrimers, G1.0(Cl)4 and G1.5(OH)8, showed perfect stability in the air environment 
at room temperature. However, G1.0(Cl)4 is not soluble in water while the G1.5(OH)8 
dendrimer is a water soluble compound. Furthermore, cell biological evaluation at the 
studied concentrations showed that the CAC, as well as the prepared G1.0(Cl)4 and 
G1.5(OH)8 dendrimers, have no cytotoxicity towards the NIH 3T3 and A2780 cell 
lines. 
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RESUMO 
No presente estudo, dois dendrímeros baseados em triazinas de baixa geração, 
G1.0(Cl)4 e G1.5(OH)8 foram sintetizados e a sua citotoxicidade foi testada através da 
utilização das linhas celulares NIH 3T3 e A2780.  
No processo de síntese do dendrímero G1.0(Cl)4, o cloreto cianúrico, que 
possui uma elevada reactividade no átomo de cloro, foi ligado aos grupos terminais do 
trietilenoglicol através da substituição nucleofílica por controlo da temperatura. O 
dendrímero G1.0(Cl)4 preparado foi purificado por coluna cromatográfica em sílica gel. 
Posteriormente, os quatro átomos de cloro do dendrímero G1.0(Cl)4 foram 
substituídos por dietanolamina, de modo a obter-se o dendrímero G1.5(OH)8 com 
grupos hidroxilo terminais.   
O material de partida cloreto cianúrico e os dendrímeros G1.0(Cl)4 e G1.5(OH)8 
foram analisados pelas técnicas de RMN unidimensional, FTIR e MS. Verificou-se que 
os dois dendrímeros G1.0(Cl)4 e G1.5(OH)8 são estáveis ao ar, à temperatura ambiente. 
Contudo, o dendrímero G1.0(Cl)4 não é solúvel em água, enquanto o dendrímero 
G1.5(OH)8 é solúvel em água. Além disso, a avaliação biológica celular nas 
concentrações estudadas, evidenciaram que o cloreto cianúrico bem como os 
dendrímeros preparados G1.0(Cl)4 e G1.5(OH)8 não apresentam citotoxicidade para as 
linhas celulares NIH 3T3 e A2780. 
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CHAPTER 1-INTRODUCTION 
1.1 Dendrimers 
1.1.1 The concept and the structural characteristics of dendrimers 
Nowadays, nanotechnology shows a very rich attraction to the scientists and 
researchers, because materials associated with this technology present completely 
different properties. Several research groups working in the field of nanotechnology are 
interested in dendrimers, a particular type of molecule with regular high structure (1). 
Dendrimers have a regular and symmetrical structure that is obtained by 
progressively repeated reactions and are the three-dimensional monodisperse type of 
macromolecules (2, 3). In 1978, Vogtle and coworkers were the first to try the use of 
“cascade” method in the preparation of dendrimers (4). Tomalia and coworkers were 
the first to synthesize a significantly active polyamidoamine (PAMAM) dendrimer 
family (5) which was coined as “starburst polymers”. Dendrimers have showed a wide 
range of potential applications such as in photoelectric sensors (6, 7), liquid crystals, 
catalysts (8, 9), pharmaceutical formulations (10, 11), gene delivery (12), surfactants, 
nano composite materials (13) and as film materials (14). 
In general, dendrimers mean that the macromolecule has a perfect dendritic 
spherical structure (Figure 1). (i) A molecule that has more than two identical chemical 
functions is used as a core; (ii) Starting from the core, branches are grown, consisting of 
repeated units, including at least one point of junction (this repetition follows some 
rules that result in different and radially concentric layers called “generations”); 
Nowadays the generation of dendrimers normally reach around 1-10 generations, and 
the molecular weight may correspond to thousands or even millions of daltons; and (iii) 
Different types of terminal groups, usually located on the surface of dendrimers; these 
surface groups are imperative to give special properties to dendrimers (15).  
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Figure 1: Outline showing the general structure of dendrimers (15). 
 
Until now, hundreds of different types of dendrimers are published in the literature, 
but only a few of them are commercially available. In Table 1, some most frequent 
dendrimers used in research are presented.  
 
Table 1: Most relevant families of dendrimers with their repeated units. 
Name Repeated units Ref.; 
Cationic PAMAM 
dendrimer  
(5,16) 
Polypropylenimine (PPI) 
dendrimer 
 
(4,17) 
Triazine dendrimer 
 
(18, 19) 
Carbosilane dendrimer 
 
(20, 21) 
Poly(PropylEtherImine) 
(PETIM) dendrimer  
(22, 23) 
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Phosphorus dendrimer 
 
(24, 25) 
Poly-L-Lysine (PLL) 
dendrimer 
 
(26, 27) 
Viologen dendrimer 
 
(28, 29) 
1.1.2 The properties of dendrimers and their unique characteristics  
Dendrimers have many features such as regular structure, high symmetry, high 
density of terminal groups, controlled relative molecular mass, intramolecular 
adjustable cavities, good hydromechanical properties, and low melt viscosity (30). 
These properties give to this kind of molecules a series of unusual characteristics such 
as a reactive behavior (their surface is easily modifiable to endow the dendrimer with 
multi-functionality), an easy film formation, and good mechanical properties (30). 
Dendrimers also are widely used for drug delivery, bioimaging, and as antiviral and 
transfecting agents (31, 32). 
1.1.3 Toxicity and safety of dendrimers 
To be used in biomedical applications, dendrimers should present low toxicity, 
be non-immunogenic (33) and also preferably biodegradable (34). For example, 
cationic dendrimers can cause cell lysis when they interact with the negative charges of 
biological membranes (35). Because the dendrimers are nanosized, they can easily 
interact with the cellular components (36). 
The cytotoxicity of dendrimers is related to the functional groups located on the 
core, branches and surface. However, the most strong influence on the cytotoxicity of 
the dendrimers comes from the terminal groups (34). According with several studies, 
dendrimers with cationic groups such as amine, guanidine, carboxylate, sulfonate, 
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phosphonate were more cytotoxic than the dendrimers with anionic groups (37). For 
that reason, PAMAM dendrimers modified with –OH groups, showed lower 
cytotoxicity than PAMAM-NH2 because the –OH groups are neutral at the 
physiological pH (38). Another way to reduce the cytotoxicity of cationic dendrimers is 
by modifying the surface of cationic dendrimers with poly(ethylene glycol) (PEG) or 
pyrrolidone (33).  
1.2 Dendrimers for biomedical applications 
As we know, PAMAM dendrimers are interesting in the biomedical area (39). 
PAMAMs have been reported to allow several cell types for high-efficiency 
transfection (40). Additionally, the use of PEG chains in dendrimer surface is good for 
dendrimers’ biocompatibility (12, 41). The work of Calabretta et al. shows that 
PAMAM dendrimers partially modified with PEG present high cytotoxicity against the 
Gram-negative bacteria Pseudomonas aeruginosa, while it is not cytotoxic to human 
corneal epithelial cells at the same concentration (42).  
1.2.1 As antimicrobials 
Nowadays, there is a huge market demand for new antimicrobials. Dendrimers 
with cationic and amphiphilic properties can disrupt the membrane of mammalian cells, 
bacteria, and fungi, thus providing new directions in the search for new antimicrobial 
agents (43). 
Chen et al. have reported a family of PPI dendrimers (Figure 2) whose 
antibacterial properties were analyzed by using a bioluminescence method. The results 
showed that the antibacterial properties are related to the size of the dendrimers, and the 
hydrophobic chain’s length (44). 
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Figure 2: Example of a PPI dendrimer with antimicrobial properties synthesized by Chen et al. (44). 
1.2.2 Dendrimers for drug delivery applications  
Dendrimers have a branched structure that offers internal cavities, which can 
help in the solubilization of medicines (45). Once most of the chemotherapeutic drugs 
present hydrophobicity, their delivery by using intravenous or intraperitoneal injections 
is limited. Also, when free drugs exist in the blood and do not enter cells, the kidneys 
can filter and remove them quickly, implying the need for multiple treatments sessions. 
Dendrimers are expected to help to overcome some of the obstacles presented before. 
Firstly, dendrimers can work like unimolecular micelles to encapsulate and solubilize 
drugs inside of their cavities (45). Secondly, if a dendrimer that carries a drug is larger 
than 5nm, the carrier’s size exceeds the renal threshold for clearance and then is less 
likely to be removed by the kidneys. So the drug can stay in the patient’s body longer 
(45). Finally, because in the normal tissues the microvascular endothelial gap is 
compact, and its structure is intact,  it is not easy for the dendrimers to pass through the 
blood vessel walls  when they have a size larger than 5 nm (45). In the tumor tissues, 
the vascular wall gaps are wider, the structure integrity of the vessels is poor, and the 
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lymphatic drainage is lacking. All these properties endow the tumor tissues with high 
selective permeability and retention for macromolecular substances. This phenomenon 
is called the high permeability and retention effect of solid tumor tissues referred to as 
the enhanced permeability and retention (EPR) effect. Therefore, the use of dendrimers 
is a passive form to target the tumor tissues and deliver chemotherapeutic drugs. 
Researchers such as Fox et al. (46) describe how dendrimer structure is related to the 
EPR effect in a very interesting review.  
There is an interesting bio-application of dendrimers called enzymatic activation 
of low generation dendritic prodrugs. These dendrimers can disassemble triggered by 
special enzymatic conditions (47). As illustrated in Figure 3, the red part is 
penicillin-G-amidase (PGA) (which release is enzymatically triggered), the blue part is 
4-nitroaniline, and the purple part are two acetylene functional groups which were used 
to connect various PEG-azide units. When this dendrimer was modified using PEG tails, 
the aqueous solubility of this dendrimer increased. 
 
Figure 3: Structure of a dendritic molecule as a drug delivery system (47). 
1.2.3 Dendrimers for gene delivery applications 
A wide variety of viral gene delivery systems has been presented to deliver 
genes into different cells. As the most capable carriers, viral vectors have their 
CHAPTER 1 - INTRODUCTION 
7 
 
limitations that consist in high carcinogenicity and immunogenicity in vivo (48). 
Non-viral vectors, in general, show lower efficiency, but they offer safety and 
flexibility (49, 50). 
Because of their monodispersity, a large number of terminal groups, and regular 
structure, dendrimers systems can be used with advantage for gene delivery (51, 52). 
For instance, the capacity of PAMAM dendrimers as gene delivery systems was 
demonstrated because they possess a huge number of cationic amines at the surface (40, 
53, 54). The positive charge of these dendrimers allow them to bind to negatively 
charged nucleic acids and, also, favor the interactions with the cell membrane (50, 55). 
Also, transfection efficiency can be improved by modifying the dendrimers with 
different groups such as alkyl chains, and membrane targeting peptides (56, 57). 
Figure 4 schematically illustrates the cells uptake of dendriplexes. In order to 
transfer the nucleic acid to cells, the dendrimer is first mixed with the nucleic acid 
resulting in charge neutralization and compaction of the DNA. After, the dendriplex 
interacts with the cell membrane that is negatively charged. Then an endosome is 
formed by cell endocytosis. Finally, the endosome suffers lysis (that is helped by the 
proton sponge effect exerted by the dendrimer inside the endosome), and the DNA is 
released in the cell interior (48). 
 
Figure 4: The process of using dendrimers to transport nucleic acids into the cells (48). 
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1.3 Triazine-based dendrimers 
The dendrimers which use 1,3,5-triazine ring as a branching unit or core are 
called triazine-based dendrimers. The triazine unit has good electron affinity, and may 
perform as an electron transport component (58). The triazine dendrimer branches 
start from the triazine ring that is usually obtained from the commercially available 
cyanuric chloride (CAC) compound. Different types of diamines are used to connect 
triazines. Due to diverse characteristics such as the length and the flexibility of 
diamines, triazine dendrimers may exhibit multiple properties (59). 
Triazine dendrimers show a wide compositional variety and can be 
synthesized to exhibit orthogonally functional surfaces appropriated for drug delivery 
applications (60). The process of triazine dendrimer synthesis can be designed (using 
reactions that are fast, chemoselectivity and with high yields) to improve the 
solubility of dendrimers and to obtain the adequate structure-activity relation (61). 
1.3.1 The properties of triazine ring as starting material in the preparation of 
dendrimers 
Triazine ring is the six-membered heterocyclic ring containing nitrogen, is 
chemically very stable, and can be decomposed by heating in concentrated sulfuric acid 
at 150 ºC (62). Due to its good stability (at a range of pH and thermal conditions), it can 
pass through a variety of harsh reaction conditions without being destroyed/ 
decomposed. Triazine ring (especially melamine) can be used in the supramolecular 
area by recognizing molecules through hydrogen bonding interaction (Figure 5). One 
system based on the interaction between melamine and CAC showed significance in 
the self-assembly of linear and cyclic hydrogen-bonded assemblies (Figure 6) (63). 
Between atoms N to N, N to O, O to O, different types of hydrogen bond were formed. 
Due to this property, it is possible to increase the water solubility of triazine dendrimers 
which have O or N atoms coupled on the triazine ring. 
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Figure 5: Sites of triazine/melamine derivatives that can act as donor or acceptor (62). 
 
 
Figure 6: Complementary hydrogen bond formation between cyanuric acid and melamine (63). 
 
The way to synthesize triazine dendrimer relies on the nucleophilic substitution 
reaction of trichlorotriazine (60). The main materials to supply the triazine ring are 
CAC, melamine, and cyanuric acid. In terms of industrial production, CAC is an 
inexpensive reagent. In the structure of CAC, three carbons connect respectively, three 
nitrogen atoms. Due to the effect of the C=N unsaturated bond, the reactivity of 
chlorine is high, and it is easy to occur nucleophilic substitution, but the active extent of 
three chlorines is different (Figure 7). The chlorine can be substituted by functional 
groups like OH, NH2, SH, NHR and form new materials with different characteristics 
and applications. When we only need to replace one chloride, the temperature of 
reaction should be controlled at temperatures of -15 to 5ºC and the reaction should be 
under the attendance of an acid-binding agent; for the removal of the second chlorine, 
the temperature should be increased to 40-60ºC and the acid-binding agent is necessary; 
the removal of the third chlorine can be achieved by keeping reaction temperature at 
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temperature 90-100ºC and the acid-binding agent presence (64). 
 
Figure 7: Chemoselective reactivity of CAC (60). 
1.3.2 The applications of triazine derivatives 
Triazine derivatives refer to the chemical compounds containing triazine 
structures. These derivatives are antibacterial, antitumor and have good optical 
properties. They are widely used in pesticides, medicine, fluorescent whitening agents, 
antioxidants, lubricants, paper treatment agents, rubber and in textile auxiliaries areas 
(37, 65). 
Kukla et al. reported the ability of triazine against the human 
immunodeficiency virus (HIV) (66). Menicagli et al. were among the first to show the 
potential of the antitumor properties of triazine derivatives, by studying the in vitro 
antitumor properties of a series of 2-alkyl-(alk-1′-ynyl,aryl)-4,6-dialkoxy-1,3,5 
-triazines derivatives (65) (Figure 8). Their findings showed that the presence of 
saturated or unsaturated moiety bonded to the heterocyclic ring via a C-C bond, as well 
as the type of the structure of the carbon-carbon bonded residue, seem to play a 
significant role in the observed cytotoxic activity.  
 
Figure 8: Triazine derivatives with antitumor properties synthesized by Menicagli et al. (65). 
1.3.3 Synthesis of triazine-based dendrimers 
Nowadays, dendrimers are usually synthesized by two methods called divergent 
(1) and convergent (2). In the divergent method, the dendrimers are started from the 
CHAPTER 1 - INTRODUCTION 
11 
 
core. More procedures are needed to achieve successive generations. In the convergent 
method, the branches/dendrons are synthesized separately and then connected to the 
core. Accordingly, the theoretical output is related to the amount of branches that are 
initially used (67). Also, other methods are used to synthesize triazine dendrimers such 
as solid phase synthesis (68).    
(1) Convergent method 
The convergent method for triazine-based dendrimers generally presents three 
steps: firstly, utilize the selectivity of CAC to get AB2 monomer; secondly, repeat the 
first step to growth AB2 and arrive to dendron; finally, connect the dendron to a 
compatible core to obtain the triazine-based dendrimer. 
The nucleophilic aromatic substitution reaction of the chloride (which are on 
the triazine rings) with phenolates was used to synthesize triazine dendrimers. To 
improve this substitution reaction, a poor electron group such as heterocyclic or the 
groups, which are connected on the heterocyclic structure are needed. Specially, it is 
more efficient to substitute the chlorine that is on the heterocyclic structure (like CAC) 
(69).  
Verheyde et al. (70) used the convergent method to synthesize a triazine-based 
dendrimer containing multiple triazine rings (Figure 9). First, through the Grignard 
reaction the AB2 monomer was obtained. The two chlorine atoms of the AB2 monomer 
reacted with two 3,5-bis-t-butylphenol that is inexpensive. Then the –CH3 of 1 (Figure 
9) was converted to –H with the presence of boron tribromide. After, two groups of 1 
were connected to AB2 (Figure 9) and the dendron was obtained. After repeating the 
above reaction to getting branches, the triazine-based dendrimer was obtained by 
choosing a suitable core like CAC (70). 
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Figure 9: The convergent method used by Verheyde et al. in the preparation of triazine-based dendrimer 
(70). 
 
Takagi et al. used CAC and p-nitrophenol as raw materials, and got the AB2 
monomer (Figure 10). Then compound 1 was prepared for the terminal groups of the 
dendrimer. To connect the –NO2 of compound 1, a reduction step was necessary. Under 
the presence of Fe/FeSO4·7H2O, the nitro group was reduced to amino-group (Figure 
10). Then the amino-group reacted easily with the chlorine atom of the triazine core by 
removal of HCl. N-generation of dendron was obtained by repeating the reaction. 
Finally, the triazine-based dendrimer was got using the CAC as the core (71). 
 
Figure 10: AB2 monomer in the preparation of triazine-based dendrimers synthesized by Takagi et al. 
(71). 
 
Recently, Enciso et al. synthesized a low generation triazine dendrimer in high 
yields by using microwave assisted reactions (72). The main advantage is that the 
nucleophilic substitution reactions on the CAC progress more rapidly with the 
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assistance of microwave, when compared to the traditional reaction approach. 
In the first reaction, to ensure the complete conversion of CAC, more than 2 
equivalents of diamine were used (Figure 11). When this reaction was finished, 
monosubstitution compounds were not discovered. The whole reaction was under the 
presence of microwave at 60 °C, and only 10 min was needed to finish this reaction. 
Finally, a clear oil product was obtained with 95% yield (72). 
For the synthesis of C2, harsher conditions were needed. 10 equivalents of 
diamine were used to reduce the product of the undesired dimer (Figure 12). This 
reaction needed more time (30 min) than the synthesis reaction of C1, and a high 
temperature (95 °C) was also needed. Finally, a clear oil product was obtained with 87% 
yield (72). 
 
Figure 11: Synthesis of low generation triazine dendrimer, C1, with the help of microwave (72). 
 
 
Figure 12: Synthesis of low generation triazine dendrimer, C2, with the help of microwave (72). 
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For the high generation of triazine dendrimers, an expected yield is not obtained, 
and traditional thermal conditions are still required. However, the microwave-assisted 
synthesis method can reduce the time for preparing low generation dendrimers and 
provides more time for the studies of high generation dendrimers (72). Depending on 
the synthesis steps, the same authors synthesized the generation 9 of this family of 
dendrimers using a macromonomer (Figure 13) (73). 
 
 
Figure 13: The macromonomer was used by Enciso et al. in which the BOC-piperazine is used to 
protect the –NH2 groups (73). 
 
 (2) Divergent method 
In the divergent method, one step is needed to protect the functional group. 
However, this approach revealed to be experimentally too complicated. CAC was 
widely used as a core to synthesize triazine dendrimers due to its selective chemical 
property of three chlorine atoms (60).  
Takagi et al. (71) used CAC and p-nitroaniline as starting material to synthesize 
compound 1. After the reduction of –NO2 groups on compound 1 (Figure 14), 
compound 2 and compound 3 were connected to give a higher generation dendrimer. 
Finally, these reactions were repeated to achieve the final triazine dendrimer. 
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Figure 14: The divergent method used by Takagi to synthesize a triazine-based dendrimer (71).  
 
Namazi and Adeli (74, 75) reported the use of PEG as the core and CAC as the 
main material to synthesize triazine-based dendrimers (G1.0, G1.5,G2.0) through the 
divergent method. The synthetic route is showed in Figure 15. In the reaction i, the PEG 
and CAC was mixed in dichloromethane, using as the base NaOH. The yield of the 
product G1.0 is 100%. In the reaction ii, excess diethanolamine (DEA) and G1.0 was 
mixed at room temperature. After refluxing for 4 h, the product G1.5 was obtained with 
100% yield. In step iii, the CAC reacted first with phenol. Then the product 4 of this 
reaction was mixed with G1.5 in dried dichloromethane under argon, using NaOH as 
the base. The yield of the obtained product generation 2 (G.2) was 70%. 
CHAPTER 1 - INTRODUCTION 
16 
 
 
 
Figure 15: The divergent method used by Namazi and Adeli (75) for the preparation of a PEG 
triazine-based dendrimer. 
 
(3) Solid phase synthesis 
Dilly et al. (68) introduced a new way to prepare triazine-based dendrimers 
using solid phase synthesis method. These kinds of dendrimers were separated from 
solid phase under the action of trifluoroacetic acid (TFA). The synthesis route is 
showed in Figure 16. First, diisopropylethylamine (DIPEA) was used as a base. The 
product 1 was obtained by the reaction of CAC with the supporting material. Then the 
product 1 reacted with ethylenediamine (ED) at 80-100ºC under the action of DIPEA, 
and the product 2 was obtained. Product 3 was achieved by the reaction of product 2 
and CAC. Yoo et al. also used solid phase approach and divergent method to synthesize 
other triazine-based dendrimers (76). 
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Figure 16: The solid-phase method used by Dilly et al. (68). 
1.3.4. The properties and applications of triazine-based dendrimers 
In general, the solubility of the triazine-based dendrimers is poor, but it can be 
improved by modifying the terminal groups or linkers of the dendrimers. The 
triazine-based dendrimers normally have good thermal oxidative stability. Kraus and 
Louw (77) used a convergent method to synthesize the triazine-based dendrimers by 
using the trimeric acid (1,3,5-benzenetricarboxylic acid) as the core and the silicon 
phthalocyanine as the functional group. The obtained triazine-based dendrimers were 
stable in the external environment and, according to the authors, can be useful for 
applications in photosynthetic materials (77). 
Due to the unique biological activity of the triazine-based dendrimers, they can 
be used in the research of antibiotics, anticancer drugs and in the drug delivery field. 
Biphenyl drugs are effective inhibitors of respiratory system virus (RSV). Nikitenko et 
al. (78) reported a kind of biphenyl compound which contains triazine ring (compound 
1 in Figure 17). This compound presented a better inhibitory activity than the biphenyl 
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compound that contains a pyrimidine analog (compound 2 in Figure 17). 
 
Figure 17: The triazine compound 1 and the pyrimidine analog 2 (78). 
 
Simanek’s group studies (79) showed that the triazine-based dendrimers can 
reduce the toxicity of drugs when they are used as drug carriers. They synthesized a 
triazine-based dendrimer molecule that can decrease the toxicity of anticancer drugs 
(methylamine purine, 6-mercaptopurine) using the injected peritoneal injection method 
(80). By mixing these drugs with triazine-based dendrimers, a good increase on the 
solubility of these drugs was observed. The mice study showed that the use of 
triazine-based dendrimers can reduce the toxicity of anticancer drugs and allow the use 
of increased doses (79, 81, 82). 
A series of aryl- triazine-based dendrimers that have conjugated systems was 
synthesized by Kim’s team (83, 84). This dendrimer family has electroluminescence 
properties and can be hopefully applied in organic light-emitting diodes. 
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Compared with the other families of dendrimers, triazine-based dendrimers are 
less studied and, despite the obtained achievements, is a promising field of study, 
particularly for the preparation of metallodendrimers. The stability and biological and 
optical activities of triazine-based dendrimers provide them with a broad prospect of 
applications. 
1.4 Objectives and General Strategy of the Project 
The objective of this project was to synthesize low generation triazine-based 
dendrimers by using, as starting materials, CAC and triethylene glycol (TEG), and test 
the cytotoxicity of the prepared compounds. Our interest in the triazine dendrimers is 
related with our previous experience in the field of the preparation of 
metallodendrimers for non-linear applications (85) and on the use of PAMAM (57) and 
PPI dendrimers as scaffolds for the preparation of low-generation ruthenium based 
metallodendrimers (86) for drug and gene delivery. The abundant possibilities to 
synthesize triazine-based dendrimers with expected solubility in aqueous environments 
and low cytotoxicity made us start a preliminary study on the preparation of these type 
of dendrimers for biological applications (e.g. drug delivery). 
As showed in Figure 18, the main synthesis process depends on the 
chemoselectivity of three different chloride atoms from the starting aromatic material, 
CAC. This molecule was connected to the core, the TEG, by a nucleophilic reaction to 
get G1.0(Cl)4. The product was purified by silica chromatography. Then the DEA was 
used to modify the G1.0(Cl)4 to get G1.5(OH)8. The products were characterized by 
nuclear magnetic resonance (NMR) techniques, Mass Spectrometry (MS), Fourier 
Transform Infrared Spectroscopy (FTIR). Finally, the cytotoxicity of these compounds 
was investigated in vitro using the NIH 3T3 fibroblast cell line of mouse (used as a 
model of normal cells) and the A2780 human ovarian carcinoma cell line (used as a 
model of cancer cells). 
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Figure 18: Synthesis process of G(OH)8 dendrimer. 
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CHAPTER 2 – MATERIALS AND METHODS 
2.1 Reagents and equipment 
CAC (purity > 99%) was purchased from ACROS ORGANICS (New Jersey, 
USA). Sodium hydroxide, chloroform, n-hexane, tetrahydrofuran (THF), 1,4-dioxane, 
TEG were bought from Thermo Fisher Scientific (MA, USA). Ethyl acetate was 
obtained from VWR (PA, USA). DEA was purchased from Sigma-Aldrich (MO, 
USA). Deuterated chloroform, deuterated dimethyl sulfoxide (DMSO), and 
diisopropylamine were bought from MERCK (Darmstadt, Germany). 
In the cytotoxicity studies, two types of cell lines were used, NIH 3T3 and 
A2780. The Dulbecco’s Modified Eagle Medium (DMEM) was acquired from 
Sigma-Aldrich (MO, USA) and to this was added 10% fetal bovine serum (FBS) and 
1% antibiotic-antimycotic (AA) and this medium was used for the NIH 3T3 cells. The 
Roswell Park Memorial Institute media (RPMI-1640) was acquired from 
Sigma-Aldrich (MO, USA) and was also used with 10% FBS and 1% AA and this 
medium was used for the A2780 cells. These media were used to culture the cells. The 
trypsin-EDTA solution was used to detach the cells from the bottom of the plates. 
NMR Spectroscopy 
Acquisition of 1H and 13C spectra was made on an NMR Spectrometer of 400 
MHz from Bruker (UltraShieldTM 400 Plus ULTRA LONG HOLD) Console 
AVANCE 400 II+.  
MS Spectroscopy 
A Mass Spectrometer type Ion Trap Multipolar LC-MSMS (Bruker Esquire 
6000 Mass Spectrometer) with Electrospray Ionization (ESI) and Atmospheric 
Pressure Chemical Ionization (APCI) sources and MSn capacity was used in the mass 
spectrometry studies.  
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FTIR spectroscopy 
The FTIR spectra were acquired using KBr pellets on a Perkin Elmer 
Spectrum Two spectrometer.  
2.2 Synthesis of the G1.0(Cl)4 dendrimer 
Under nitrogen atmosphere, a solution of CAC (17.08g, 92.6mmol) in 50ml of 
dry THF (Solution 1) was prepared and a solution of TEG (6.95g,46.3mmol) with 
N,N-DIPEA (16.1ml, 46.3mmol) in 6ml of dry THF at 0 °C (a water solution with salt 
and ice was used to control the temperature) (Solution 2). Then, these two solutions 
were mixed as showed in Figure A1 in the ANNEX, at 0°C, under a nitrogen 
atmosphere. After being stirred for 27 h at 0°C, the mixture was filtered, and the 
obtained white solid was washed with 20 ml of THF. The excess solvent was 
evaporated using a rotary evaporator system. The white solid was purified by silica gel 
column chromatography using a mixture of hexane and ethyl acetate with a ratio of 4:1. 
Finally, the product (which was from silica gel column) was washed with hexane to 
remove the ethyl acetate. Finally 5.5g of G1.0(Cl)4 was obtained as a white solid (yield: 
26.6%). 1H NMR (CDCl3, 400 MHz) [δ: 4.627, 4.634, 4.638, 4.642, 4.650(m, 4H); 
3.843, 3.851, 3.854, 3.858, 3.866 (m, 4H); 3.683 (s, 4H)].13C NMR (CDCl3, 400 MHz) 
[δ: 60.55, 68.69, 69.46, 71.02, 172.721]. IR (KBr) ν: 2920 (-CH2), 1384 (-C-Cl) cm-1. 
2.3 Synthesis of the G1.5(OH)8 dendrimer  
Because 1,4-dioxane combines with atmospheric oxygen upon prolonged 
exposure to air, forming potentially explosive peroxides, this reaction was processed in 
a three neck flask (250mL) under nitrogen.  
In a flask, 25 mL of 1, 4-dioxane was added to 2.5g of G1.0 (Cl)4 (5.6 mmol) under 
stirring. Then, the solution was moved under a nitrogen atmosphere to a three neck 
flask. 
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We added DEA（2.7mL，28mmol）to the solution of G1.0(Cl)4 drop wise. Then 
sodium hydroxide solution (0,9g, 22.4mmol NaOH in 1 ml water) was added as a base 
(its molar ratio to G1.0(Cl)4 was 4:1). This mixture was stirred for 0.5h at room 
temperature, then the temperature was increased to 80 °C and refluxed for 4.0h. At the 
end of the reaction, the mixture was filtered by using a vacuum filter funnel. The excess 
of 1,4-dioxane was removed using a rotary evaporator (under 17mbar, at 37 °C 
conditions), the filtrate was dispersed and washed with THF and acetone, filtered again, 
and the filter cake was dried  using the rotary evaporator. Finally, the product was 
washed with acetone to remove the impurities:1.24 g of G1.5(OH)8 was obtained as a 
white oil (yield: 33.3%). 1H NMR (DMSO-d6, 400 MHz) [δ:4.683, 4.694, 4.706, 4.724, 
4.736, 4.749 (m,8H); 4.272, 4.284, 4.295 (t,4H); 3.672, 3.661, 3.684 (tri, 4H); 3.568(s, 
36H)]. IR (KBr) ν: 3382 (-OH), 2948 (-CH2), 2879 (-CH2), 1583 (-C=N-), 1520 
(-C=N-), 1342 (-CH2) cm
-1. MS (ESI) [M+H] + m/z: calcd. for C28N10O12H52, 720.77; 
found, 721.4. 
2.4 Cell Biological Evaluation 
The NIH 3T3 and A2780 cell lines were used to evaluate the cytotoxicity of 
CAC, G1.0(Cl)4 and G1.5(OH)8. First, NIH 3T3 fibroblasts and A2780 cells were 
plated in 96-well plates. After 24h, the old media were removed and complete medium 
and the test solutions (10μL of DMSO, CAC-DMSO, G1.0(Cl)4-DMSO and 
G1.5(OH)8-DMSO solutions ) were added to the cell culture wells and then incubated 
for 48 h, at 37 °C. Medium and DMSO were used as controls. 
The resazurin reduction assay was chosen to measure the cellular metabolic 
activity to conclude about the cell viability. Then the medium was removed; the wells 
were filled with fresh medium containing 10% of resazurin, and the cells were kept in 
the incubator for 3 h. After 3 h, the medium with resazurin was transferred to 96-well 
white opaque plates and the resorufin fluorescence (λex=530nm, λem=590 nm) was read 
by using a microplate reader (model Victor3 1420, PerkinElmer). 
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One-way ANOVA statistical analyzes with Tukey’s test was chosen to evaluate 
the statistical significance of experimental data. All results are reported as mean ± SD. 
0.05 was selected as the significance level, and the data was indicated with (**) for p < 
0.01 and (***) for p <0.001, respectively. 
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CHAPTER 3 – RESULTS AND DISCUSSION 
3.1 Synthesis and characterization of G1.0(Cl)4 dendrimer 
Due to the chemoselectivity and by controlling temperature, CAC is used to 
synthesize a large number of triazine-based dendrimers. 
In this work, two equivalents of CAC were connected to TEG as a core. The 
oxygen atoms in the chain of TEG can improve the polarity of the final dendrimer and 
form H-bonding with H2O, which can increase the solubility of the final dendrimer in 
aqueous solution. 
The 1H NMR spectrum of G1.0(Cl)4 in CDCl3 is shown in Figure 19. The peak 
shift at 7.260 ppm is from CDCl3. The solvent impurities originating from column 
chromatography are depicted as (d) and (e) in Figure 19. 
 
 
Figure 19: 1H NMR spectrum of G1.0(Cl)4 in CDCl3. 
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In Figure A2 in the ANNEX, we have the 1H NMR of hexane prepared in 
CDCl3 acquired from the Spectral Database for Organic Compounds (SDBS). In the 
1H 
NMR spectrum of G1.0(Cl)4 in Figure 19, signals at δ: 0.890, 1.271, 1.280  correspond 
to hexane. Compared with the 1H NMR of ethyl acetate in CDCl3 obtained from the 
SDBS (see ANNEX, Figure A3), the signals indicated at (e) in the 1H NMR spectrum of 
G1.0(Cl)4 were from ethyl acetate. 
In the 1H NMR spectrum  of TEG in CDCl3 (see ANNEX, Figure A4) there 
are peaks at 3.721, 3.711 and 3.700 ppm (these peaks are labeled as A in the Figure); 
3.652 ppm (this peak is labeled  as C in the Figure); 3.599, 3.587 and 3.577 ppm (these 
peaks are labeled as B in the Figure). In Figure 19, a single peak at C which has a 
chemical shift at 3.683 ppm (s, 4H) is related with the single peak at 3.652 ppm (s,4H) 
observed in the SDBS spectrum for the TEG starting material. Due to the position of the 
carbon in the middle of G1.0(Cl)4, which is indicated as C in the chemical structure in 
Figure 19,  the chemical shift of the proton at this carbon C was not influenced by the 
atoms from the G1.0(Cl)4 termini. 
When the oxygen atom from the -OH group of TEG was connected with CAC, 
the protons at carbon A in the G1.0(Cl)4 chemical structure (see Figure 19) were less 
shielded. So the signal of the protons at carbon A in G1.0(Cl)4 moved to the left. The 
signals of the protons at carbon A should be [δ: 4.627, 4.634, 4.638, 4.642 and 4.650 
ppm (m, 4H)] and the peaks of the protons at carbon B [δ: 3.843, 3.851, 3.854, 3.858 
and 3.866 ppm (m, 4H)]. 
The 13C NMR spectrum of ethyl acetate has four signals at 171.080, 60.440, 
21.000 and 14.280 ppm (SDBS). Looking at the 13C NMR spectrum of G1.0(Cl)4, in 
Figure 20, the observed peaks at 14.348, 20.299, 21.182, and 171.233 ppm correspond 
to ethyl acetate.  
The 13C NMR spectra  in Figure 20 also revealed a relevant peak with a 
chemical shift at 172.721 ppm for both CAC and G1.0(Cl)4. This means that there is a 
triazine ring in the G1.0(Cl)4 product. 
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Figure 20: 13C NMR of G1.0(Cl)4, TEG and CAC in CDCl3. 
 
In the 13C NMR spectrum of TEG, there are 3 signals at 72.791, 70.431, and 
61.675ppm. The 13C NMR spectrum of G1.0(Cl)4 presents peaks at 71.016, 69.461, 
68.689 and 60.546 ppm that belong to the TEG core, confirming that the connection 
between TEG and CAC was successful. 
The 1H NMR spectrum of the G1.0(Cl)4 compound acquired at room 
temperature after two weeks confirmed its stability. 
 
3.2 Synthesis and characterization of the G1.5(OH)8 dendrimer 
As presented in Figure 21, DEA was used to increase the generation and the 
solubility of the dendrimer in solution. 
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Figure 21: Synthesis of G1.5(OH)8. 
 
The results of the solubility test for G1.5(OH)8 in solvents with different 
polarity are presented in Table 2. Except DMSO, water, dimethyl formamide (DMF) 
and methanol, the other pure solvents cannot dissolve the product even at 60 °C. The 
table shows that only solvents with higher polarity (except acetonitrile) and a mixture 
of dioxane:methanol (9:3) can dissolve G1.5(OH)8 totally. 
 
Table 2: Solubility of G1.5(OH)8 in selected organic solvents or mixture of solvents at room 
temperature. 
Solvent 
Polarity*  Solubility at Room 
Temperature 
Methylene chloride 3.10 No obvious dissolution 
Tetrahydrofuran 4.00 No obvious dissolution 
Chloroform 4.10 No obvious dissolution 
Ethyl acetate 4.40 No obvious dissolution 
Dioxane 4.80 No obvious dissolution 
Acetone 5.10 No obvious dissolution 
Methanol 5.10 Well dissolved 
Acetonitrile 5.80 No obvious dissolution 
DMF 6.40 Well dissolved 
DMSO 7.20 Well dissolved 
Water 10.20 Well dissolved 
Dioxane:Methanol=9:3  Well dissolved 
*The polarity index of the different solvents was obtained from LSU Macromolecular Studies Group. 
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Comparing the 1H NMR spectra of G1.5(OH)8 and G1.0(Cl)4, the most relevant 
difference corresponds to peak D in Figure 22, which can be attributed to the proton of 
the –OH groups from the G1.5(OH)8 termini. As the spectrum showed, the shape of this 
signal is two triplets instead of the expected wide single peak of the –OH. Probably, the 
main reason for the observed effect on the proton peaks (8H) comes from the fact that 
DMSO may be bound to one or two –OH groups depending on the concentration 
(87).As to peaks A, B and C of G1.5(OH)8, it is similar to G1.0(Cl)4 according to 
compare Figure 19 with Figure 22. 
 
 
Figure 22: 1H NMR spectrum of G1.5(OH)8 in DMSO. 
3.3 The MS spectrum of G1.5(OH)8 dendrimer 
The mass spectrum of the G1.5(OH)8  dendrimer in MeOH (Figure 23) 
presents two special fragments. One fragment was the molecular peak M=721.4 that is 
in accordance with the molecular weight of G1.5(OH)8 dendrimer and the other one at 
M=436.1 corresponds to the half of G1.5(OH)8 dendrimer. The peak 743.4 is probably 
formed by the reaction between of G1.5(OH)8 with Na
+. 
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Figure 23: The mass spectrum of G1.5(OH)8 in MeOH. 
3.4 The FTIR spectrum of CAC, G1.0(Cl)4 dendrimer and G1.5(OH)8 
dendrimer 
The characteristic vibrations of the chemical bonds in the functional groups of 
any prepared compound will display special bands in the FTIR spectrum (88). So we 
can use FTIR spectroscopy to compare different molecules to find the relationship 
between different compounds. In Table 3 the IR spectrum vibrational bands obtained 
for the materials prepared in this work are compared with those obtained from 
Bio-Rad database.  
 
Table 3: Comparison of IR spectrum stretching vibrations of the materials in this work and those 
obtained from the database. 
Bonds Data from this work Stretching vibration* 
C-Cl 1270, 1384 cm-1 1200-1000 cm-1 
C=N 1498, 1583, 1520 cm-1 1500 cm-1 
-OH 3463, 3382 cm-1 3650-3320 cm-1 
CH2 2920, 2948, 2879, 1342 cm
-1
 2936-2843 cm-1  
1485-1445 cm-1 
*Stretching vibration values obtained from the Bio-Rad data base (http://www.bio-rad.com/) 
In Figure 24a, the peak (as = 1498 cm-1) is from the –C=N- of CAC. This 
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band also appeared in the spectrum of Figure 24c, which wavenumbers are as = 1583 
cm-1 and as = 1520 cm-1, respectively. In the case of spectrum 24b, the stretching 
vibration of –C=N- is unclear. The peaks at as = 1270 cm-1 in Figure 24a and as = 
1384 cm-1 in Figure 24b are from –C-Cl of CAC. In Figure 24b and 24c, the 
maximum at as = 1342 cm-1, as = 2879 cm-1, as = 2920 cm-1 and as = 3382 cm-1 are 
attributed to the –CH2 bonds. In Figure 24c, the stretching vibration –OH correspond 
to as = 3382 cm-1. In Figure 24b, there is a wide peak (as = 3463 cm-1). Considering 
that KBr was used to prepare the FTIR sample, maybe the type and amount of sample 
in the KBr, the preparation of the FTIR sample and the quantity of moisture in the 
KBr matrix affect the resolution of the IR analysis. Comparing the achieved results 
with the NMR and MS data (in the case of G1.5(OH)8), we can confirm the successful 
preparation of the desired dendrimers. 
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Figure 24: The FTIR spectrum of CAC (a), G1.0(Cl)4 dendrimer (b) and G1.5(OH)8 dendrimer (c). 
3.5 In Vitro Cytotoxicity of CAC, G1.0(Cl)4 dendrimer and G1.5(OH)8 
dendrimer 
The application of triazine-based dendrimers in the biological field depends on 
their inherent toxicities, which can hinder or limit their biological applications. The in 
vitro cytotoxicity of CAC , G1.0(Cl)4 dendrimer  and G1.5(OH)8 dendrimer  were 
tested by using NIH 3T3 and A2780 cell lines. The resazurin reduction assay showed 
the results of cell viability (see Figures 25 and 26). The wells that only had medium 
were used as a control. A second control used a mixture of medium (either DMEM or 
RPMI-1640) with DMSO since this solvent was used to dissolve the tested compounds. 
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As shown in Figures 25 and 26, the viability of cells in the presence of CAC, G1.0(Cl)4 
dendrimer and G1.5(OH)8 dendrimer exceeded 80% in the concentration range 1 µM to 
100 µM for both cell lines. As such, the compounds present very low toxicity within the 
selected concentration range.  
  
Figure 25: Cytotoxicity evaluation of CAC, G1.0(Cl)4 dendrimer and G1.5(OH)8 dendrimer at 
different concentrations for 48 h and for NIH 3T3 cells using resazurin reduction assay. All results were 
expressed as the mean ±SD, n =3. One-way ANOVA with Tukey’s test was used to assess the statistical 
difference between the group means (**p <0.01, *** p <0.001). 
 
Figure 26: Cytotoxicity evaluation of CAC, G1.0(Cl)4 dendrimer and G1.5(OH)8 dendrimer at 
different concentrations for 48 h and for A2780 cells using resazurin reduction assay. All results were 
expressed as the mean ±SD, n =3. One-way ANOVA with Tukey’s test was used to assess the statistical 
difference between the group means (**p <0.01, *** p <0.001). 
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Figures 27 and 28 make a comparison between the cytotoxicity of G1.0(Cl)4 
dendrimer and G1.5(OH)8 dendrimer for increasing compound concentrations and for 
NIH 3T3 cells and A2780 cells. G1.0(Cl)4 and G1.5(OH)8  have respectively  
significant difference on the toxicity of these two kinds of cells. 
  
Figure 27: Comparison of the cytotoxicity of G1.0(Cl)4 dendrimer at different concentrations 
between NIH 3T3 cells and A2780 cells after 48h. All results were expressed as the mean ±SD, n =3. 
One-way ANOVA with Tukey’s test was used to assess the statistical difference between the group 
means (**p <0.01, *** p <0.001). 
 
Figure 28: Comparison of the cytotoxicity of G1.5(OH)8 dendrimer at different concentrations 
between NIH 3T3 cells and A2780 cells after 48h. All results were expressed as the mean ±SD, n =3. 
One-way ANOVA with Tukey’s test was used to assess the statistical difference between the group 
means (**p <0.01, *** p <0.001). 
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The inherent toxicity of dendrimers hinder their application in pharmaceutical 
field (89) and, compared with the interior groups, the surface groups is much more 
active to influence the toxicity of dendrimers (60). In general, when the surface charge 
of dendrimers is cationic, the dendrimers show high toxicity. The main reason for that 
behavior is related with the fact that cationic charges can interact with the biological 
membranes that are negatively charged. As a result of this interaction, the cell 
membrane can be disrupted due to the creation of nanoholes (89). The terminal atoms 
of the dendrimer G1.0(Cl)4 are chloride atoms that are very electronegative (90). So, 
the surface of G1.0(Cl)4 is rich in electrons and presents a negative character. Oxygen is 
also an electronegative atom. Once the dendrimer G1.5(OH)8 has 8 –OH terminal 
groups, its surface also has a strong negative character. For these reasons the toxicity of 
our dendrimers is low. 
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GENERAL CONCLUSIONS 
In summary, the G1.0(Cl)4 dendrimer and the G1.5(OH)8 dendrimer were 
synthesized and characterized by using common synthesis techniques. These two 
dendrimers showed good stability on the atmospheric air at room temperature. 
Importantly, once the G1.5(OH)8 dendrimer displays a good solubility in water (and 
DMSO), it is possible to foresee their use in biological applications. CAC, G1.0(Cl)4 
and G1.5(OH)8 dendrimer do not have cytotoxicity according to the results of the 
resazurin reduction assay with 0-100 µM concentrations. 
During this work, special techniques of organic chemistry were used, as well 
as common and advanced synthesis techniques, to confirm the preparation of the 
reported triazine-based dendrimers. Despite the small number of results obtained in 
the time available, it is expected that they can open the way for the preparation of 
higher dendrimer generations for biological applications, particularly for drug 
delivery.  
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Figure A1: The way to transfer one solution to another one under nitrogen condition. 
 
Figure A2: 1H NMR spectrum of hexane in CDCl3. 
 
Figure A3: 1H NMR spectrum of ethyl acetate in CDCl3. 
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Figure A4: 1H NMR spectrum of TEG in CDCl3. 
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